Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
APPROVALS
Page 2
APPROVALS
APPROVALS
FDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy
Tess Egginton
-
7th June 2022
0
APPROVALS
FDA approves RIABNI (rituximab-arrx), a biosimilar to Rituxan (rituximab), for adults with moderate to severe rheumatoid arthritis
Tess Egginton
-
7th June 2022
0
APPROVALS
FDA approves first treatment for eosinophilic esophagitis, a chronic immune disorder
Tess Egginton
-
23rd May 2022
0
APPROVALS
WHO validates 11th vaccine for COVID-19
Tess Egginton
-
23rd May 2022
0
APPROVALS
MHRA approves faricimab for progressive eye diseases through international work-sharing initiative
Tess Egginton
-
18th May 2022
0
APPROVALS
FDA approves Lilly’s Mounjaro injection for type 2 diabetes
Tess Egginton
-
18th May 2022
0
APPROVALS
FDA approves Lilly and Incyte’s OLUMIANT (baricitinib) for hospitalized patients with COVID-19
Tess Egginton
-
13th May 2022
0
APPROVALS
Enhertu approved in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen
Tess Egginton
-
11th May 2022
0
APPROVALS
Novartis receives European Commission approval for Jakavi to be the first post-steroid treatment for acute and chronic graft-versus-host disease
Tess Egginton
-
6th May 2022
0
APPROVALS
RINVOQ approved by U.S. FDA as an oral treatment for adults with active ankylosing spondylitis
Tess Egginton
-
5th May 2022
0
1
2
3
...
10
Page 2 of 10